Search Results - "Rueda, Ana Gómez"

Radiation recall pneumonitis: PET/CT findings by Gorospe, Luis, Martín-Martín, Margarita, Paredes-Rodríguez, Patricia, Gómez-Rueda, Ana

Get full text

Percutaneous imaging‐guided biopsies in patients with COVID‐19 positive cancer performed at the peak of the COVID‐19 pandemic by Gorospe, Luis, Ayala‐Carbonero, Ana María, Mirambeaux‐Villalona, Rosa Mariela, Benito‐Berlinches, Amparo, Gómez‐Rueda, Ana, Fra‐Fernández, Sara, Muñoz‐Molina, Gemma María, González‐García, Andrés

Get full text

Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer by Alfranca, Yolanda Lage, Garcia, María Eugenia Olmedo, Rueda, Ana Gómez, Ballesteros, Pablo Álvarez, Rodríguez, Diana Rosero, Velasco, Marisa Torres

“…Immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of non-small cell lung cancer (NSCLC), either used in monotherapy or in…”
Get full text

Response to Mobocertinib in a patient with advanced Non-Small Cell Lung Cancer harboring EGFR exon 20 insertion after several therapies including Amivantamab by Corral de la Fuente, Elena, Olmedo García, María Eugenia, Orejana Martín, Inmaculada, Benito Berlinches, Amparo, Gómez Rueda, Ana, Lage Alfranca, Yolanda, Garrido, Pilar

“…Patients harboring EGFR exon 20 insertion (EGFRex20ins) advanced Non-Small Cell Lung Cancer (NSCLC) represent a poor prognosis population of oncogene-addicted…”
Get full text

Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design by Garrido, Pilar, Pujol, Jean-Louis, Kim, Edward S, Lee, Jay M, Tsuboi, Masahiro, Gómez-Rueda, Ana, Benito, Amparo, Moreno, Nicolas, Gorospe, Luis, Dong, Tuochuan, Blin, Cecile, Rodrik-Outmezguine, Vanessa, Passos, Vanessa Q, Mok, Tony Sk

“…Canakinumab is a human IgGκ monoclonal antibody, with high affinity and specificity for IL-1β. The Canakinumab Anti-Inflammatory Thrombosis Outcome Study…”
Get full text

Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance by Zugazagoitia, Jon, Gómez-Rueda, Ana, Jantus-Lewintre, Eloisa, Isla, Dolores, Camps, Carlos, Ramos, Inmaculada, Trigo, Jose Manuel, Bernabé, Reyes, Juan-Vidal, Oscar, Sanchez-Torres, Jose Miguel, García-Campelo, Rosario, Provencio, Mariano, Felip, Enriqueta, de Castro, Javier, Faull, Iris, Lanman, Richard B., Ponce-Aix, Santiago, Paz-Ares, Luis, Garrido, Pilar

“…•Multicenter prospective study including 53 EGFR/ALK/ROS1-TKI-resistant patients.•Thirty-four patients (64%) had evidence of tumor-DNA shed for resistance…”
Get full text

New horizons for uncommon mutations in non-small cell lung cancer: BRAF , KRAS , RET , MET , NTRK , HER2 by Olmedo, Maria Eugenia, Cervera, Raquel, Cabezon-Gutierrez, Luis, Lage, Yolanda, Corral de la Fuente, Elena, Gómez Rueda, Ana, Mielgo-Rubio, Xabier, Trujillo, Juan Carlos, Couñago, Felipe

“…The 2004 discovery of mutations, followed by rearrangements, ushered in a targeted therapy era for advanced non-small cell lung cancer (NSCLC). Tyrosine kinase…”
Get full text

Nivolumab-induced pneumonitis complicated by cyst formation by Gorospe, Luis, Ayala-Carbonero, Ana María, Olmedo-García, María Eugenia, Gómez-Rueda, Ana, Palka, Magda, Mezquita, Laura, Garrido-López, Pilar

Get full text

Pulmonary aspergilloma mimicking synchronous lung cancer on PET/CT in a patient with head and neck cancer by Gorospe, Luis, Arrieta, Paola, Ajuria-Illarramendi, Odile, Barbolla-Díaz, Ignacio, Muñoz-molina, Gemma María, Gómez-Rueda, Ana, Moreno-Mata, Nicolás

Get full text

Challenges in Management of Patients With Lung Cancer in Times of COVID-19: An Imaging Perspective by Gorospe, Luis, Ayala-Carbonero, Ana María, Paredes-Rodríguez, Patricia, Muñoz-Molina, Gemma María, Arrieta, Paola, Mirambeaux-Villalona, Rosa Mariela, Vallejo-Ocaña, María Carmen, Benito-Berlinches, Amparo, Lage-Alfranca, Yolanda, Gómez-Rueda, Ana

Get full text

Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report by Pozas, Javier, Albarrán-Fernández, Víctor, González-Campo, Luis, Olmedo-García, María Eugenia, Corral de la Fuente, Elena, Corral-Corral, Iñigo, Carrasco, Ángela, Alonso-Gordoa, Teresa, Molina-Cerrillo, Javier, Lage-Alfranca, Yolanda, Gómez-Rueda, Ana, Garrido, Pilar

“…Paraneoplastic cerebellar degeneration (PCD) is one of the most prevalent neurological paraneoplastic syndromes, typically associated with small cell lung…”
Get full text

NUT midline carcinoma causing critical stenosis of the coronary arteries: CT demonstration by Gorospe, Luis, Ayala-Carbonero, Ana María, Farfán-Leal, Frank Eric, Muñoz-Molina, Gemma María, Olmedo-García, María Eugenia, Gómez-Rueda, Ana, Garrido-López, Pilar

Get full text

Efficacy of immunotherapy in sarcomatoid lung cancer, a case report and literature review by Kotlowska, Magda Palka, Rueda, Ana Gómez, Olmedo, María Eugenia, Benito, Amparo, Roldán, Almudena Santón, Fernandez Méndez, Maria Angeles, Gorospe, Luis, Palacios, José, Garrido López, Pilar

“…Sarcomatoid carcinoma is a subtype of non-small cell lung cancer (NSCLC) characterized by mesenchymal – epithelial transition component and awful prognosis. In…”
Get full text

ALK rearranged non–small cell lung carcinoma with EML4-NTRK3 fusion as a possible mechanism of resistance to third-generation ALK inhibitors by Corral de la Fuente, Elena, Benito Berlinches, Amparo, Gomez Rueda, Ana, Olmedo García, María Eugenia, Lage Alfranca, Yolanda, Lario, Margaret, Santón Roldán, Almudena, Garrido, Pilar

“…•Echinoderm microtubule associated protein-like 4 (EML4)- anaplastic lymphoma kinase (ALK) fusion is the most common in NonSmall Cell Lung Cancer (NSCLC)…”
Get full text

Targeting KRAS in Non-Small Cell Lung Cancer by Corral de la Fuente, Elena, Olmedo Garcia, Maria Eugenia, Gomez Rueda, Ana, Lage, Yolanda, Garrido, Pilar

“…Kirsten Rat Sarcoma viral oncogene homolog (KRAS) is the most frequently altered oncogene in Non-Small Cell Lung Cancer (NSCLC). KRAS mutant tumors constitute…”
Get full text

Clinical Activity of Afatinib in Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study by Moran, Teresa, Taus, Alvaro, Arriola, Edurne, Aguado, Carlos, Dómine, Manuel, Rueda, Ana Gómez, Calles, Antonio, Cedrés, Susana, Viñolas, Nuria, Isla, Dolores, Palmero, Ramón, Sereno, María, Diaz, Victor, Juan, Oscar, Marsé, Raquel, Martorell, Paloma Martín, Sánchez Torres, José Miguel, Anguera, Georgia, Bosch, Joaquim, Cabezón, Luis, Catot, Silvia, Martinez, Alex, Muñoz, Silvia, Ramos, Inmaculada

“…Uncommon epidermal growth factor receptor (EGFR) mutations (u-EGFRm) are a heterogeneous group of molecular alterations and have also been reported as…”
Get full text

The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy by Gómez Rueda, Ana, Taus, Álvaro, Álvarez Álvarez, Rosa, Bernabé-Caro, Reyes, Chara, Luis, López-Brea, Marta, Vilà, Laia, Sala González, Maria Ángeles, del Barrio Díaz Aldagalán, Anabel, Esteban Herrera, Beatriz, López Castro, Rafael, Álvarez Cabellos, Ruth, Doménech, Marta, Falagan, Sandra, Moreno Vega, Alberto, Aguado, Carlos, Barba, Andrés, Delgado Ureña, Maria Teresa, Isla, Dolores, Bellido Hernández, Lorena, Fírvida Pérez, José Luis, Juan-Vidal, Óscar, Massutí, Bartomeu, Mielgo-Rubio, Xabier, Ortega, Ana Laura, Catot, Silvia, Dómine, Manuel, Escoín-Pérez, Corina, García Navalón, Francisco, Gil-Bazo, Ignacio, Muñoz, Silvia, Rodríguez-Abreu, Delvys, Villatoro Roldán, Rosa María, Alonso-Jáudenes Curbera, Guillermo, León-Mateos, Luis, Padilla, Airam, Paredes Lario, Alfredo, Sánchez-Torres, José Miguel, Garrido, Pilar

“…Objectives The S-REAL study aimed to assess the effectiveness of durvalumab as consolidation therapy after definitive chemoradiotherapy (CRT) in a real-world…”
Get full text

First-in-human dose escalation of monalizumab plus durvalumab, with expansion in patients with metastatic microsatellite-stable colorectal cancer by Segal, Neil Howard, Naidoo, Jarushka, Curigliano, Giuseppe, Patel, Sandip, Sahebjam, Solmaz, Papadopoulos, Kyriakos P., Gordon, Michael S., Wang, Ding, Gómez Rueda, Ana, Song, Xuyang, Li, Xia, Marshall, Shannon, Abdullah, Shaad Essa, Diamond, Jennifer Robinson

“…Abstract only…”
Get full text

Clinical utility of plasma-based digital next-generation sequencing (NGS) in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping by Zugazagoitia, Jon, Ramos Garcia, Inmaculada, Trigo Perez, Jose Manuel, Palka, Magda, Gómez Rueda, Ana, Jantus-Lewintre, Eloisa, Camps, Carlos, Isla, Dolores, Ponce Aix, Santiago, Campelo, Rosario Garcia, Provencio-Pulla, Mariano, Bernabe Caro, Reyes, Juan Vidal, Oscar, Felip, Enriqueta, De Castro, Javier, Sanchez Torres, Jose Miguel, Faull, Iris, Lanman, Richard B., Garrido Lopez, Pilar, Paz-Ares, Luis G.

“…Abstract only…”
Get full text

Circulating biomarkers exploratory study in loco-regional gastroesophageal adenocarcinoma patients by Longo, Federico, Earl, Julie, Martinez-Avila, Jose Carlos, Guerrero, Carme, Pachon, Vanesa, Rodríguez Garrote, Mercedes, Ferreiro, REYES, Gómez Rueda, Ana, Molina, Javier, Villamayor Delgado, Maria, Martinez Saez, Olga, Salgado, Alfonso Cortes, Muñoz del Toro, Jacobo, Cortez Castedo, Silvia Patricia, Olmedo Garcia, Maria Eugenia, Lopez Hervas, Pedro, Priego, Pablo, Galindo, Julio, Guillén Ponce, Carmen, Carrato, Alfredo

“…Abstract only 17 Background: Patients diagnosed with gastroesophageal adenocarcinoma (GEA) have a poor prognosis despite curative attempts with multimodal…”
Get full text